Department of Infectious Disease at Imperial College London | Part of the Faculty of Medicine | Innovating new approaches to infectious disease control on a global scale
https://www.imperial.ac.uk/infectious-disease/
Department of Infectious Disease
Loading...
A new HIV treatment could let people safely pause daily medication.💊
The @riotrial.bsky.social found that immune-based therapy enabled 75% of participants to stop ART for 20 weeks, potentially offering a longer-lasting alternative treatment.👇
www.imperial.ac.uk/news/article...
Join us on 30 June for a seminar with Prof John Briggs (Max Planck Institute).
Discover his cutting-edge research on “in situ” structural biology of HIV-1 & Influenza.
📅 30 June 2026
⏰ 13:00–14:00
📍 South Kensington / Online
www.imperial.ac.uk/events/20364...
Join us next Monday for another lecture from Dr Tulika Singh.
She will be presenting a talk on 'Development of human antibody and B cell responses against flaviviruses'.
🗓️ 11 May, 11:00am
📌 South Kensington
Researchers CBRB welcomed colleagues from WACCBIP as part of an Imperial Global Connect visit.
The event aimed to strengthen international partnerships and advance discovery research in bacterial antimicrobial resistance (AMR). 🔬
www.imperial.ac.uk/news/article...
Antibiotics are losing their effectiveness, and routine treatments could become impossible.
Featuring work from our Dr Tim Rawson and Dr Andy Edwards, this @nature.com video explores the threat of antimicrobial resistance and the race for solutions.
Watch now👇
www.youtube.com/watch?v=B5zB...
Congratulations to Prof Paul Kellam on his election to the
@acmedsci.bsky.social Fellowship 👏
A leader in virus genomics, his work on viral evolution, pathogen genomics and antiviral immunity has shaped global responses to outbreaks.
👉 imperial.ac.uk/news/article...
The UK has joined a major clinical trial to test an mRNA vaccine for H5N1 influenza.
Prof John Tregoning (@prof-tregoning.bsky.social) says large‑scale trials are vital to efforts to adapt rapidly and scale production before the next pandemic.
www.telegraph.co.uk/global-healt...
Could a simple blood test predict how an illness will unfold?🩸
Scientists at @imperialinfect.bsky.social have developed VeloCD, a method that can forecast disease progression and treatment response — with potential to transform patient care. 🔽
www.imperial.ac.uk/news/article...
Congratulations to Prof Michael Way on being elected a Fellow of the Royal Society 🎉
Professor @imperialcollegeldn.bsky.social and group leader @crick.ac.uk, his work has shaped a wider understanding of cell signalling and host-pathogen interactions.
www.crick.ac.uk/news/2026-05...
New research shows that flu infection may increase susceptibility to tuberculosis (TB) by weakening key immune pathways.
The findings suggest seasonal flu vaccines could offer a new tool to help prevent TB in high-risk regions. 💉 👇️
www.imperial.ac.uk/news/article...
New research from Imperial College London suggests that infection with the influenza virus may leave people more susceptible to tuberculosis.
A major clinical trial has shown that an immune-based treatment allows people living with HIV to safely stop daily therapy and could offer a longer-a...
You are seeing this page because our security systems have detected some unusual activity on this connection. To regain access to The Telegraph website please try the following:
